Concepedia

Daniel Lorch

DL

Statistics

Publications

14

Citations

4.7K

H-Index

14

Active since

1986

Affiliations

Medical University of South Carolina(Current)

University of Toronto

Universidad de La Frontera

St. Michael's Hospital

Yonsei University Health System

Daniel Lorch is an author at Medical University of South Carolina specializing in medicine, pulmonology, and pharmacology.

ORCID

Publications per year

1986–2023

14

Publications

14

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy

Nicholas J. Pastis, Lonny Yarmus, Frank Schippers et al. · CHEST Journal · 2018 · 314 citations

, , +7

Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial

Douglas K. Rex, Raj Bhandari, Daniel Lorch et al. · Digestive and Liver Disease · 2020 · 164 citations · Full text

, , +15

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

Toby M. Maher, Paul Ford, Kevin M. Brown et al. · JAMA · 2023 · 127 citations · Full text

, , +10

1–5 of 14